Abstracts Archive - Page 110 of 1683 - ATC Abstracts

2022 American Transplant Congress
Impact of Delayed Graft Function in Donation After Circulatory Death Kidney Transplantation
J. Mello Offerni¹, H. Brar¹, D. Lee¹, M. Levine², M. Mandurah¹, S. Rim¹, A. Sener¹, P. Luke¹
¹Urology, Western University, London, ON, Canada, ²Division of Urology, Department of Surgery, University of Alberta, Edmonton, AB, Canada
*Purpose: Donation after circulatory death (DCD) has been associated with higher rates of delayed graft function (DGF) when compared to donation after brain death (DBD).…
2022 American Transplant Congress
MELD -Na 15 and Lower – Way to Go Forward- DCD Liver Transplant or Wait for a Higher MELD Score ?
V. Vetrivel Venkatasamy¹, P. Abreu¹, J. Riella², R. Shah³, R. Miyashiro², G. Selvaggi³, A. Tekin², R. Vianna³
¹Department of Surgery, Division of Liver and GI Transplantation, University of Miami, Miami, FL, ²University of Miami, Miami, FL, ³University of Miami/Jackson Memorial Hospital, Miami, FL
*Purpose: Liver transplantation following donation after cardiac death (DCD) continues to be a subject for heated debate, bigger controversy is if MELD score of 15…
2022 American Transplant Congress
The Effect of Baseline Blood Pressure on Early Graft Function in Deceased Donor Kidney Transplantation
B. Jun Bae¹, C. Oh¹, H. Ahn²
¹Department of surgery, Ajou University Medical School, Suwon, Korea, Republic of, ²Department of Anesthesiology and Pain medicine, Ajou University Medical School, Suwon, Korea, Republic of
*Purpose: The adequate perfusion pressure to the graft is essential for proper graft function in kidney transplantation, especially in deceased donor kidney transplantation. Therefore, the…
2022 American Transplant Congress
Performance of Kidney Transplantation in a Resource-Poor Setting of Southeast Nigeria- A Review of the First Ten Cases
C. G. Okwuonu¹, O. J. Chimezie², G. O. Achor³, N. M. Erondu⁴, C. Ralph-Iheke⁵, S. Alhassan⁶
¹INTERNAL MEDICINE/NEPHROLOGY, Federal Medical Centre, Umuahia, Nigeria, ²OPTOMETRY, Federal Medical Centre, Umuahia, Nigeria, ³SURGERY/UROLOGY, Federal Medical Centre, Umuahia, Nigeria, ⁴ANAESTHESIA, Federal Medical Centre, Umuahia, Nigeria, ⁵NURSING SERVICES DIVISION, Federal Medical Centre, Umuahia, Nigeria, ⁶SURGERY/UROLOGY, Aminu Kano Teaching Hospital, Kano, Nigeria
*Purpose: To assess complication and survival after performance of kidney transplantation in a resource poor setting in Southeast Nigeria*Methods: A retrospective review of transplant registers…
2022 American Transplant Congress
Living Related Kidney Donation for Alport Syndrome Spectrum: Long-Term Outcomes
Y. Caliskan¹, A. B. Dirim², S. Safak², B. Yelken³, A. Velioglu⁴, A. Yildiz⁵, O. A. Oto², N. Guller², H. Yazici², A. Ersoy⁵, A. Turkmen³, K. L. Lentine¹
¹Saint Louis University, Saint Louis, MO, ²Istanbul University, Istanbul, Turkey, ³Koc University Hospital, Istanbul, Turkey, ⁴Marmara University, Istanbul, Turkey, ⁵Uludag University, Bursa, Turkey
*Purpose: Data to guide the evaluation of living related donor (LRD) candidates for kidney transplant recipients with Alport syndrome (AS) spectrum are limited. We examined…
2022 American Transplant Congress
Team Decision-Making in Liver Transplant Evaluation: A Multi-Center Ethnographic Observation Study
C. N. Sidoti, H. C. Sung, D. L. Segev, M. L. Levan, T. S. Purnell, A. T. Strauss
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: Transplant providers are tasked with making ethically complex and high-stakes decisions of determining a patient’s candidacy for liver transplantation within a multi-disciplinary team. We…
2022 American Transplant Congress
A Novel Non-Invasive Urine Method for Assessment of Kidney Dysfunction
R. Sarwal¹, W. Yazar¹, N. Titzler¹, M. Sarwal², S. Ghosh¹
¹Nephrosant, Brisbane, CA, ²NephroSant, San Francisco, CA
*Purpose: A recent cohort study of 10 869 living kidney donors from ImmPort highlighted that 14.7% have postdonation events unto 40 yrs later, relating to increased…
2022 American Transplant Congress
Sars-cov-2 Antibody and T Cell Response After Vaccination with or without Intensified Immunosuppression Among Pediatric Renal Transplant Recipients
H. Pizzo¹, B. Shin², P. R. Soni³, S. Nadipuram³, J. Garrison², R. Zhang², S. C. Jordan², D. Puliyanda¹
¹Pediatric Nephrology, Cedars-Sinai Medical Center, Los Angeles, CA, ²Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, ³Pediatric Infectious Disease, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Recent data has shown poor antibody response to SARS-CoV-2 vaccination among adult kidney transplant (tx) recipients, with seroconversion ranging between 22%-58% after two mRNA…
2022 American Transplant Congress
Implementation of Modified Multi-Point Screening in Selection Criteria for Kidney Transplant Candidates
M. E. Welborn, S. Thuppal, K. Delfino, R. Bounds, M. Hazelrigg, M. R. Garfinkel
Division of General Surgery, Department of Surgery, Southern Illinois University, Springfield, IL
*Purpose: In 2016, the Springfield Memorial Hospital (SMH) Transplant Program implemented a modified assessment for all renal transplant candidates undergoing evaluation in an effort to…
2022 American Transplant Congress
The Impact of Early Graft Infiltrating TCF-1^LowPD-1^HighCD8⁺ T Cells in Delayed Fc Nonbinding Anti-CD3 Antibody Protocol in the Sensitized Mouse Model
T. Ota¹, R. Goto¹, T. Harada¹, Y. Ganchiku¹, M. Zaitsu¹, A. Forgioni¹, N. Kawamura², M. Watanabe², M. Fukai¹, T. Shimamura³, A. Taketomi¹
¹Dept. of Gastroenterological Surgery I, Hokkaido University, Sapporo, Japan, ²Dept. of Transplant Surgery, Hokkaido University, Sapporo, Japan, ³Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan
*Purpose: Fc nonbinding anti(a)-CD3 antibody has a unique effect that delayed treatment protocol induces a transplant tolerance. Delayed protocol allows early graft infiltrating cells which…